BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ren M, Wang Y, Luo Y, Yao X, Yang Z, Zhang P, Zhao W, Jiang D. Functionalized Nanoparticles in Prevention and Targeted Therapy of Viral Diseases With Neurotropism Properties, Special Insight on COVID-19. Front Microbiol 2021;12:767104. [PMID: 34867899 DOI: 10.3389/fmicb.2021.767104] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ren M, Zhou Y, Tu T, Jiang D, Pang M, Li Y, Luo Y, Yao X, Yang Z, Wang Y. RVG Peptide-Functionalized Favipiravir Nanoparticle Delivery System Facilitates Antiviral Therapy of Neurotropic Virus Infection in a Mouse Model. Int J Mol Sci 2023;24:5851. [PMID: 36982925 DOI: 10.3390/ijms24065851] [Reference Citation Analysis]
2 da Silva TN, de Lima EV, Barradas TN, Testa CG, Picciani PHS, Figueiredo CP, do Carmo FA, Clarke JR. Nanosystems for gene therapy targeting brain damage caused by viral infections. Mater Today Bio 2023;18:100525. [PMID: 36619201 DOI: 10.1016/j.mtbio.2022.100525] [Reference Citation Analysis]
3 Kotarkonda LK, Sinha TP, Bhoi S, Bharathala S. Role of nanocomposites for the prevention and treatment of viral infections in the health care system. Smart Nanomaterials to Combat the Spread of Viral Infections 2023. [DOI: 10.1016/b978-0-323-99148-3.00012-1] [Reference Citation Analysis]
4 Tong T, Tang W, Xiao S, Liang J. Antiviral Effects of Heparan Sulfate Analogue‐Modified Two‐Dimensional MXene Nanocomposites on PRRSV and SARS‐CoV‐2. Advanced NanoBiomed Research 2022. [DOI: 10.1002/anbr.202200067] [Reference Citation Analysis]
5 Chandra S, Hu T. From Prevention to Therapy: A Roadmap of Nanotechnologies to Stay Ahead of Future Pandemics. ACS Nano 2022. [PMID: 35793456 DOI: 10.1021/acsnano.2c04148] [Reference Citation Analysis]